IART Berita Forex

Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Medical technology firm Integra LifeSciences Holdings Corp. (IART) announced Wednesday that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company, for $275 million in cash at closing. This is subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
RTTNews | 322 hari yang lalu